The FDA gave San Diego company NuVasive expanded 510 (k) clearance for the company’s Precice system, which treats patients with limb length discrepancy and deformities.
BIOTECH: Cancer Treatment Times to Be Reduced Up to 30%
UC San Diego Health is now one of only two centers in the world with an advanced radiation therapy machine that’s expected to shorten cancer patient treatment times by 20 percent to 30 percent.
BIOTECH: Tandem May Gain Patients While DexCom Might Lose Users
Johnson & Johnson’s announcement that it will exit the insulin pump businesses appears to benefit one San Diego company, Tandem Diabetes Care, and potentially hurt another, DexCom.
HEALTH: Alternatve Therapies Pushed by Physician Groups
Today’s national health crisis comes in pill form — i.e. opioid use. American Specialty Health is offering a possible solution that could reduce opioid use by relying on a combination of methods — including so-called alternative options — targeted to individuals for the treatment of pain.
Spinal surgery and medical device company NuVasive has filed a breach-of-contract lawsuit against former President, COO and Vice Chairman Patrick Miles, who resigned from the company and took a position as Alphatec Spine’s executive chairman.
Quidel Corp. has managed to close a previously precarious deal with East Coast diagnostic firm Alere Inc. that could potentially double Quidel’s annual revenue.
The stock price for San Diego drugmaker AnaptysBio has more than doubled in a matter of hours following news that the company’s experimental drug performed well in a recent study.
Healthcare firm Grifols Diagnostic Solutions Inc. of Los Angeles has acquired an industrial warehouse in San Diego’s 4S Ranch neighborhood for $14.63 million.
San Diego’s AMN Healthcare ranked No. 11 on Fortune’s 100 Fastest Growing Companies list.
Two San Diegans have been tapped for the newly established Governor's Advisory Committee on Precision Medicine.
BIOTECH: Arizona Co. Gets License; Aim Is for Cost to Be Less Than Dollar
Qualcomm Life Inc. plans to take a disposable biometric patch that monitors vital signs to market with the help of a corporate partner by 2018.
BIOTECH: Co. Gets $1.4M in Seed Funding, $1.53M in Crowdfunding
A company that recently released a headset that claims to facilitate weight loss through brain stimulation has brought in $1.53 million via a crowdfunding campaign. It’s also raised skepticism, and highlighted the difference between medical products and wellness devices.
BIOTECH: Co Has Solid Product, Medicare Reimbursement OK
DexCom doesn’t appear to be panicking despite the San Diego company’s shares tanking after the Food and Drug Administration’s approval of a rival glucose monitoring product.
UnitedHealthcare is now offering a health benefit plan to Medi-Cal beneficiaries in San Diego County.
Drugmaker Zogenix Inc. saw its value more than double over the weekend, so those following San Diego biotech might think the local company is making a comeback.